Human Health business is conducted through Human Biologicals Institute (HBI), a division of Indian Immunologicals Ltd. It was formed in the
year 1998, when the Govt. of India requested IIL to produce a modern
tissue culture anti- rabies vaccine in order to phase out the unsafe
Nerve Tissue Vaccine (NTV). The first manufacturing facility of HBI was
set up at Ooty in 1998, one of the largest of its kind in India that has
rolled out first Vero cell culture rabies vaccine in 2000. The
manufacturing units conform to WHO-GMP, ISO 9001: 2015, EMS 14001:2015 and OHSAS 18001:2007 standards.
IIL set up its other manufacturing
facilities at Hyderabad for DPT, DT, TT and Hepatitis-B vaccine. This
Plant was inaugurated by the then Honorable President of India, Late Dr.
A. P. J. Abdul Kalam in 2003. Today, IIL is a leading player in human
vaccine segment, both in single and multiple dosage forms.
Today Human Health division of IIL has
emerged as a leading player in the vaccine segment in India and Nepal.
In year 2014 IIL has forayed into clinically proven wellness products
that will enrich the overall health. The marketing arm of Human Health
reaches the entire geography of India and Nepal through valued products
and services in line with the Vision Mission of IIL.